高兴一回 发表于 2025-3-23 09:52:41

New Directions in Failure to Thrivemunotherapy has attained a lot of considerations for its unique applications and hopeful future. Chemotherapy and radiotherapy are conventional therapeutic methods which are lacking particular targeting and consequent off-target effects. Because of these drawbacks, it has started searching for techn

Mercantile 发表于 2025-3-23 17:17:42

New Directions in Failure to Thrive significant limitations of conventional therapeutic agents in treating breast cancer. In recent years, researchers have concentrated on creating nanomedicine platforms to overcome the limitations associated with traditional anticancer therapies. Simultaneous diagnosis and treatment (theranostics) o

Pseudoephedrine 发表于 2025-3-23 22:01:53

http://reply.papertrans.cn/23/2212/221161/221161_13.png

beta-carotene 发表于 2025-3-24 00:40:02

Elizabeth F. Gordon,Delia M. Vazquezagriculture, electronics, medicine, insecticides, pharmaceuticals, metals, large-scale industries, etc. Among nanoparticle synthesis using chemical and biological synthesis methods, biologically synthesized nanoparticles especially from plant-derived nanoparticles are currently attracting researcher

妈妈不开心 发表于 2025-3-24 05:59:08

http://reply.papertrans.cn/23/2212/221161/221161_15.png

大都市 发表于 2025-3-24 08:37:14

http://reply.papertrans.cn/23/2212/221161/221161_16.png

Misgiving 发表于 2025-3-24 14:11:36

Quratulain Syed,Ned Wilson Holland Jr.ced novel therapies and modern approaches of diagnosis, the spectacle of cancer therapy and diagnosis has grasped a significant leap over the past few decades. Despite many such efforts, the growing needs for treatment and diagnosis are still unmet, and there is a time gap between treatment and diag

的事物 发表于 2025-3-24 15:20:20

http://reply.papertrans.cn/23/2212/221161/221161_18.png

lethargy 发表于 2025-3-24 20:25:17

http://reply.papertrans.cn/23/2212/221161/221161_19.png

PAC 发表于 2025-3-24 23:55:52

http://reply.papertrans.cn/23/2212/221161/221161_20.png
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Cancer Nanotheranostics; Volume 2 Muthupandian Saravanan,Hamed Barabadi Book 2021 The Editor(s) (if applicable) and The Author(s), under ex